U.S. Physical Therapy, Inc. (USPH)
NYSE · Healthcare · Medical Care Facilities
$83.96+0.29%as of Oct 6, 2026, 1:35 AM ET
- Market cap
- $1.3B
- P/E (trailing)
- 466.4
- Forward P/E
- 25.1
- Dividend yield
- 2.2%
- 52-week range
- $58.19 – $93.50
- 52-week change
- −6.74%
- EPS (trailing)
- $0.18
- Next earnings
- Nov 4, 2026
Fiscal year to Dec 2025
- Revenue
- $781M (+16.33%)
- Net income
- $39.6M
- Operating margin
- 11.1%
- Diluted EPS
- $1.42
- Free cash flow
- $61.0M
From the company’s annual report on SEC EDGAR.
About U.S. Physical Therapy, Inc.
U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.
Headquarters: Houston, United States · 4,653 employees · usph.com